ChiCTR1800014394 版本V1.2 版本创建时间2020/07/01 23:06:16 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR1800014394 

最近更新日期:

Date of Last Refreshed on:

2020-07-01 22:58:23 

注册时间:

Date of Registration:

2018-01-10 00:00:00 

注册号状态:

补注册

Registration Status:

Retrospective registration

注册题目:

二胎政策下的高危孕产妇管理

Public title:

High-risk maternal management under the two-child policy

注册题目简写:

English Acronym:

研究课题的正式科学名称:

二胎政策下的高危孕产妇管理

Scientific title:

High-risk maternal management under the two-child policy

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

张勇 

研究负责人:

范建霞 

Applicant:

Zhang Yong 

Study leader:

Fan Jianxia 

申请注册联系人电话:

Applicant telephone:

+86 13916472189

研究负责人电话:

Study leader's
telephone:

+86 18017316031

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

yzhang415@163.com

研究负责人电子邮件:

Study leader's E-mail:

fanjianxia122@126.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

上海市衡山路910号

研究负责人通讯地址:

上海市衡山路910号

Applicant address:

910 Hengshan Road, Shanghai, China

Study leader's address:

910 Hengshan Road, Shanghai, China

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

国际和平妇幼保健院

Applicant's institution:

International Peace Maternity and Child Health Hospital

研究负责人所在单位:

国际和平妇幼保健院

Affiliation of the Leader:

International Peace Maternity and Child Health Hospital

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

GKLW 2016-69

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

国际和平妇幼保健院医学科研伦理委员会

Name of the ethic committee:

International peace maternity and child health hospital medical research ethical committee

伦理委员会批准日期:

Date of approved by ethic committee:

2016-03-07 00:00:00

伦理委员会联系人:

许泓

Contact Name of the ethic committee:

Xu Hong

伦理委员会联系地址:

上海市衡山路910号

Contact Address of the ethic committee:

910 Hengshan Road, Shanghai, China

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

国际和平妇幼保健院

Primary sponsor:

International peace maternity and child health hospital

研究实施负责(组长)单位地址:

上海市衡山路910号

Primary sponsor's address:

910 Hengshan Road, Shanghai, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

上海市

市(区县):

徐汇区

Country:

China

Province:

Shanghai

City:

Shanghai

单位(医院):

国际和平妇幼保健院

具体地址:

上海市衡山路910号

Institution
hospital:

International peace maternity and child health hospital

Address:

910 Hengshan Road, Shanghai

经费或物资来源:

上海市卫生局

Source(s) of funding:

Shanghai Bureau of Health

研究疾病:

妊娠期内分泌疾病  

Target disease:

Gestational Endocrinology Disease

研究疾病代码:

Target disease code:

研究类型:

观察性研究

Study type:

Observational study

研究所处阶段:

探索性研究/预试验 

Study phase:

0

研究设计:

单臂 

Study design:

Single arm 

研究目的:

本项目对孕妇进行系统化管理,建立高龄产科代谢性疾病诊治中心,对妊娠期糖尿病、妊娠期甲状腺疾病的临床大数据进行分析,整合最新的研究技术,为临床诊断和治疗提供新的策略。  

Objectives of Study:

This project carries out a systematic management for pregnant women,aiming to establish a diagnosis and treatment centre of elderly gestational endocrinology disease and to analysize clinical data of gestational diabetes and gestational thyroid disease,integrated with latest research technics,providing new strategies for clinical diagnosis and treatment.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

(1)18岁以上 (2)单胎 (3)中国汉族 (4)知晓并同意参与本研究项目

Inclusion criteria

(1) Age≥18 years old;
(2) Single birth;
(3) Chinese Han women;
(4) Know and agree to participate in this research project.

排除标准:

(1)孕前糖尿病 (2)多囊卵巢综合症 (3)辅助生殖受孕 (4)产检数据缺失

Exclusion criteria:

(1) Pre-pregnant diabetes;
(2) Polycystic ovary syndrome;
(3) Assisted reproductive infertile;
(4) Missing medical records.

研究实施时间:

Study execute time:

From 2018-01-01 00:00:00 To 2020-12-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2018-01-01 00:00:00 To 2020-12-31 00:00:00

干预措施:

Interventions:

组别:

孕妇

样本量:

400

Group:

gestational women

Sample size:

干预措施:

控制体重

干预措施代码:

Intervention:

weight control

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

上海市 

市(区县):

徐汇区 

Country:

China

Province:

Shanghai

City:

Shanghai

单位(医院):

国际和平妇幼保健院 

单位级别:

三级甲等 

Institution
hospital:

International peace maternity and child health hospital

Level of the institution:

Tertiary A Hospital

测量指标:

Outcomes:

指标中文名:

血糖

指标类型:

主要指标

Outcome:

plasma glucose

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

胎粪

组织:

Sample Name:

meconium

Tissue:

人体标本去向

使用后保存  

说明

Fate of sample:

Preservation after use  

Note:

征募研究对象情况:

Recruiting status:

正在进行

Recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age 50 years

性别:

女性

Gender:

Female

随机方法(请说明由何人用什么方法产生随机序列):

NA

Randomization Procedure (please state who generates the random number sequence and by what method):

NA

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

Blinding:

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

否No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

原始数据会在试验完成后通过发表中文核心期刊或者SCI的方式共享

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

The raw data will be shared through the publication of the core journals or SCI after the test is completed

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

数据采集和管理权限与方法归本院信息科所有

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Data collection and management authority and methods belong to the information section of the institute

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2018-01-10 20:28:34